lysergic acid diethylamide has been researched along with Cardiac Diseases in 2 studies
Lysergic Acid Diethylamide: Semisynthetic derivative of ergot (Claviceps purpurea). It has complex effects on serotonergic systems including antagonism at some peripheral serotonin receptors, both agonist and antagonist actions at central nervous system serotonin receptors, and possibly effects on serotonin turnover. It is a potent hallucinogen, but the mechanisms of that effect are not well understood.
lysergic acid diethylamide : An ergoline alkaloid arising from formal condensation of lysergic acid with diethylamine.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Simonsson, O | 1 |
| Sexton, JD | 1 |
| Hendricks, PS | 1 |
| Stalport, J | 1 |
| Dardenne, A | 1 |
| Letawe, P | 1 |
| Boddaert, J | 1 |
2 other studies available for lysergic acid diethylamide and Cardiac Diseases
| Article | Year |
|---|---|
Associations between lifetime classic psychedelic use and markers of physical health.
Topics: Adult; Body Mass Index; Drug Users; Female; Hallucinogens; Health Status; Heart Diseases; Humans; Ly | 2021 |
[Carcinoid tumor of the small intestine].
Topics: Aged; Anemia; Bromine; Carcinoid Tumor; Cecum; Chlorpromazine; Diarrhea; Glucocorticoids; Heart Dise | 1971 |